Clinical trial Recruiting at 2 sites Observational Ages 18 to 45 Women only

Monitored effects of physical activity on fetal heart rate with a wireless non-invasive monitor

Official title: Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device

Run by Balgrist University Hospital · NCT06813859 · Data updated 2026-11-12

This study tests whether a wireless, non-invasive device can reliably track fetal heart rate during exercise in pregnant athletes.

More Fetal Distress trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment20 (estimated)
SponsorBalgrist University Hospital
Academic / other
Locations2 sites (Zurich, Canton of Zurich and 1 other locations)
StatusRecruiting
StartedJune 30, 2025
Main results expectedOctober 31, 2026
Study endsFebruary 27, 2027
Registry record updatedJuly 9, 2026
Trial IDNCT06813859 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy pregnant women 18–44 years old, 28+0 to 34+0 weeks gestation, active exercisers (>4 hours/week on at least 2 weekdays) with informed consent.

Probably not a fit

Pregnant individuals outside the specified gestational window, with pre-existing pregnancy complications, or those not meeting the fitness criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will first assess whether the Nemo Healthcare Monitoring System can accurately measure fetal heart rate compared with standard Doppler ultrasound and whether measurements are consistent within and between observers. It will also explore how maternal exercise affects fetal heart rate patterns, blood flow, and placental–fetal circulation. If the initial step shows validity and reliability, a larger study will examine changes in these parameters across different levels of exertion. The project uses an observational design with an exercise testing intervention in otherwise healthy pregnant participants between 28 and 34 weeks gestation.

Why it matters

Potential benefit: If successful, the device could enable continuous, non-invasive fetal monitoring during physical activity.

How similar studies have gone: Previous work with CTG devices suggests feasibility for continuous fetal monitoring, but the specific wireless, non-invasive approach and exercise context is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Presence of signed informed consent form
* healthy pregnant active female over the age of 18 years and below 45 years
* sporting activity \>4h/week on 2 or more weekdays
* single pregnancy, between 28+0 and 34+0 weeks of pregnancy

Exclusion Criteria:

* No signed informed consent form or revocation of consent
* pre-existing pregnancy complications

Where it's running

  • Balgrist University Hospital
    Zurich, Canton of Zurich, Switzerland
    Recruiting
  • University Hospital Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Dark chocolate to prompt a non-reactive fetal NST to become reactive

    This will test whether one 30 g serving of dark chocolate (≥80% cocoa) given to pregnant women at 36–41 weeks with a non-reactive NST helps the fetal heart-rate tracing become reactive within 20 minutes compared with a sugar-free white chocolate placebo.

    Recruiting Universidad Nacional Autonoma de Honduras · Tegucigalpa, Francisco Morazán Department · NCT07418151

  • Improving heart assessment in fetuses and newborns

    This study is testing new ways to check the heart health of unborn babies and newborns to help prevent serious problems during delivery.

    Recruiting Oslo University Hospital · Oslo · NCT06186973

  • Oxygen supplementation for mothers during labor to help babies in distress

    This study is testing if giving extra oxygen to mothers during labor can help their babies who are in distress feel better and avoid complications.

    Recruiting Washington University School of Medicine · St Louis, Missouri · NCT05681624

  • New sensor for monitoring fetal health during late pregnancy

    This study is testing a new non-adhesive sensor to see if it can accurately monitor the heart rates of pregnant women and their babies during late pregnancy.

    Recruiting University of Manchester · Manchester · NCT06952777

  • Ophthalmic Artery Doppler to predict labor problems before induction

    This study tests whether measuring the ophthalmic artery Doppler in pregnant people at term who are being induced can help predict intrapartum fetal distress.

    Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, rm · NCT07846137

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.